ERBB2 and breast carcinoma: Despite the observed cytotoxic effect of ZSC extract against HER2-positive breast cancer cell lines ZR-75-1 and SK-BR-3, there was no noticeable effect either on the viability or the morphology of non-cancerous cell line MCF-10A, which was used as a control for safety evaluation.